Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings ...

HSBC analyst warns of a downside in Eli Lilly stock to $700. Rajesh Kumar cited 'valuation' as his number 1 concern.

Mounjaro, the new weight loss drug, is gaining popularity in India for its rapid results. Patients report better appetite control, blood sugar management, and significant weight loss.

Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate ...

With its 2-star rating, we believe Lilly stock is overvalued compared with our long-term fair value estimate of $650 per ...

Top US firms are boosting executive security spending after the killing of UnitedHealth’s Brian Thompson, with costs expected ...

Many of the world's biggest companies are sitting on millions -- sometimes hundreds of millions -- of dollars in unused or ...

Best friends since preschool, Avery Baker and Millie Becker have shared a lot over the years. This week, the Marietta High ...

Castlewood and Deuel square off in Class B high school softball battle during a triangular with Oldham-Ramona-Rutland ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

The Class A boys championship trophy presentation wasn't well attended with athletes Saturday at the Goshen Relays. Concord's boys won the title with 114 points, with only a handful of their team at ...